Mortality Trends and Disparities in Cardiovascular Disease and Amyloidosis: A Retrospective Population Study in the United States (1999–2020) - Summary - MDSpire
Advertisement
Mortality Trends and Disparities in Cardiovascular Disease and Amyloidosis: A Retrospective Population Study in the United States (1999–2020)
To evaluate trends and disparities in amyloidosis and cardiovascular disease (CVD)-related deaths, particularly focusing on demographic factors such as race and socioeconomic status, using U.S. national mortality data from 1999 to 2020.
Key Findings:
Total of 26,391 deaths attributed to amyloidosis and CVD from 1999 to 2020, highlighting a significant public health issue.
AAMR increased from 4.4 per 1,000,000 in 1999 to 9.31 per 1,000,000 in 2020, indicating a concerning trend.
Overall AAMR showed an annual percent change (APC) of 3.49, with significant increases noted after 2012, suggesting a need for targeted interventions.
Interpretation:
The rising mortality rates indicate a growing public health concern regarding the intersection of amyloidosis and cardiovascular disease, particularly among older adults, necessitating enhanced awareness and intervention strategies.
Limitations:
Study relies on mortality data, which may underrepresent the true prevalence of amyloidosis due to underdiagnosis, potentially skewing mortality rates.
Analysis is limited to deaths with co-coded conditions, potentially overlooking other relevant mortality factors and their impact on health disparities.
Conclusion:
The study highlights the urgent need for improved diagnostic awareness and management strategies for amyloidosis in the context of cardiovascular disease, particularly to address disparities in outcomes among different demographic groups.
